Extreme Option Profits Chart of Day…Ocugen (OCGN)

Oversold, OCGN is gaining momentum.

According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN also exhibited 70% efficacy against asymptomatic cases, which could be vital in thwarting asymptomatic spread.”

The stock is up about 17% in pre-market to $11.25 and running.

 

This is just one of the opportunities we find quite often inside Extreme Option Profits. 

 

  • Takes LESS Than 10 Minutes a Week
  • Averaged 32.26% Gains in Weekly Income Over the Last Year
  • Made 1,677.96% Returns in the Last 12 Months